JNJ(JNJ)
JNJ
Consensus
Buy3.63 / 519 ratings · Strong Buy 0 · Buy 12 · Hold 7 · Sell 0 · Strong Sell 0
Avg target $278.00+7.6%Median $282.00High $320.00Low $208.0017 targets in the last 12 months1 rating older than 2 years not counted
Price vs average target
Revenue and EPS estimates
| Reported | Consensus estimates | |||||||
|---|---|---|---|---|---|---|---|---|
| Fiscal period | FY2023Dec '23 | FY2024Dec '24 | FY2025Dec '25 | FY2026Dec '26 | FY2027Dec '27 | FY2028Dec '28 | FY2029Dec '29 | FY2030Dec '30 |
| Revenue (B) | 85.16 | 88.82 | 94.19 | 101.32 | 108.79 | 117.50 | 125.75 | 135.04 |
| Growth YoY | −6.6% | +4.3% | +6.0% | +7.6% | +7.4% | +8.0% | +7.0% | +7.4% |
| High estimate | – | – | – | 101.55 | 110.16 | 120.32 | 127.53 | 136.95 |
| Low estimate | – | – | – | 100.97 | 106.53 | 114.74 | 124.01 | 133.18 |
| Analysts | – | – | – | 9 | 8 | 5 | 2 | 2 |
| EPS, adjusted | 10.43 | 9.99 | 10.80 | 11.35 | 12.50 | 14.29 | 16.28 | 18.16 |
| Growth YoY | +2.7% | −4.2% | +8.1% | +5.1% | +10.2% | +14.3% | +14.0% | +11.5% |
| High estimate | – | – | – | 11.69 | 13.39 | 14.55 | 16.58 | 18.50 |
| Low estimate | – | – | – | 10.84 | 11.30 | 14.03 | 15.99 | 17.84 |
| Analysts | – | – | – | 7 | 6 | 1 | 1 | 1 |
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
23 firms active in the last 12 months
| Firm | Analyst | Rating | Prev rating | Target | Prev target | Chg | Upside | Date |
|---|---|---|---|---|---|---|---|---|
| Guggenheim | Vamil Divan | Buy | Buy | $287.00 | $270.00 | +6% | +11% | Oct 7 |
| RBC Capital | Shagun Singh | Outperform | Outperform | $290.00 | $287.00 | +1% | +12% | Oct 6 |
| Citigroup | – | Buy | Buy | – | – | – | – | Oct 5 |
| JP Morgan | – | Neutral | Neutral | – | – | – | – | Sep 29 |
| New Street | – | – | – | $278.00 | – | – | +8% | Sep 29 |
| HSBC | – | Buy | Buy | $320.00 | $290.00 | +10% | +24% | Sep 10 |
| UBS | – | Buy | Buy | $320.00 | $214.00 | +50% | +24% | Sep 2 |
| Raymond James | – | Outperform · Jul 2026 | Outperform | $280.00 | $265.00 | +6% | +8% | Aug 3 |
| Wells Fargo | – | Overweight | Overweight | $282.00 | $272.00 | +4% | +9% | Aug 3 |
| Argus Research | David Toung | Buy · Mar 2020 · not counted | Buy | $300.00 | $210.00 | +43% | +16% | Jul 29 |
| Goldman Sachs | Asad Haider | Buy · Dec 2025 | Buy | $282.00 | $250.00 | +13% | +9% | Jul 16 |
| Johnson Rice | Ilya Zubkov | – | – | $280.00 | $270.00 | +4% | +8% | Jul 16 |
| Morgan Stanley | Terence Flynn | Overweight | Overweight | $294.00 | $284.00 | +4% | +14% | Jul 16 |
| Scotiabank | – | Sector Outperform · Jan 2026 | Sector Outperform | $305.00 | $265.00 | +15% | +18% | Jul 16 |
| Stifel Nicolaus | Rick Wise | Hold · Apr 2026 | Hold | $260.00 | $250.00 | +4% | +1% | Jul 15 |
| TD Cowen | – | Buy | Buy | – | – | – | – | Jul 13 |
| B of A Securities | – | Neutral | Neutral | – | – | – | – | Jul 10 |
| Leerink Partners | David Risinger | Outperform | Market Perform | $265.00 | $194.00 | +37% | +3% | May 13 |
| Barclays | Matt Miksic | Equal Weight | Equal Weight | $255.00 | $217.00 | +18% | −1% | Apr 15 |
| Freedom Broker | – | Hold | Hold | – | – | – | – | Jan 27 |
| Freedom Capital Markets | – | Hold | Hold | – | – | – | – | Jan 27 |
| Loop Capital Markets | Ilya Zubkov | – | – | $220.00 | $190.00 | +16% | −15% | Jan 27 |
| Bernstein | Lee Hambright | Market Perform | Market Perform | $208.00 | $193.00 | +8% | −19% | Jan 9 |
Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data
Explore More
Healthcare Stocks
More Healthcare stocks
JNJ vs PFE
Compare JNJ and PFE side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers